Form 4 Filing for Beta Bionics, Inc. - Insider Transaction

Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), reported the sale of 1,258 shares of common stock on June 24, 2026. The shares were sold at an average price of $15.0083 per share, with a price range between $15.00 and $15.015. This transaction was conducted under a Rule 10b5-1 Plan adopted on May 13, 2025. Following the sale, Hopman directly owns 129,354 shares of common stock. The filing indicates that full information regarding the number of shares sold at each separate price will be provided upon request by the SEC, the Issuer, or any security holder.